Completed NA INTERVENTIONAL 2-arm NCT03355651

Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction

Prospective Study for Assess Efficacy and Tolerability of an Oral Supplement Based on Collagen, HC-15 and Plasmatic Proteins, in the Recovery of ACL After Surgery: a Multicenter, Randomized, Controlled Trial

Sponsor: OPKO Health, Inc.

Conditions ACL Reconstruction

Interventions PROGEN

Updated 6 times since 2017 Last updated: Nov 28, 2017 Started: Mar 9, 2015 Primary completion: Feb 1, 2017 Completion: Mar 3, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on ACL Reconstruction, this trial is completed. The trial is conducted by OPKO Health, Inc. and has accumulated 6 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Oct 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Dec 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

OPKO Health, Inc.

Data source: OPKO Health, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.